Validation of an MRI-only planning workflow for definitive pelvic radiotherapy.
Laura M O'ConnorJason A DowlingJae Hyuk ChoiJarad MartinHelen Warren-ForwardHaylea RichardsonLeah BestKate SkehanMahesh KumarGeetha GovindarajuluSwetha SridharanPeter B GreerPublished in: Radiation oncology (London, England) (2022)
A multi-atlas based method for sCT generation can be applied to a standard T1-weighted MRI sequence for male and female pelvic patients. The implications of this study support MRI only planning being applied more broadly for both male and female pelvic sites. Trial registration This trial was registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) ( www.anzctr.org.au ) on 04/10/2017. Trial identifier ACTRN12617001406392.
Keyphrases
- clinical trial
- contrast enhanced
- phase iii
- phase ii
- magnetic resonance imaging
- rectal cancer
- study protocol
- locally advanced
- end stage renal disease
- diffusion weighted imaging
- open label
- magnetic resonance
- newly diagnosed
- chronic kidney disease
- ejection fraction
- computed tomography
- early stage
- randomized controlled trial
- radiation therapy
- squamous cell carcinoma
- sensitive detection
- double blind
- patient reported outcomes
- radiation induced
- amino acid
- quantum dots
- reduced graphene oxide
- clinical evaluation